Burden of respiratory syncytial virus infections in China: Systematic review and meta–analysis

Burden of respiratory syncytial virus infections in China: Systematic review and meta–analysis

Respiratory syncytial virus (RSV) is the most important cause of acute respiratory tract infection (ARTI) related morbidity and mortality worldwide. However, the disease burden due to RSV has not been systematically summarized in China. A systematic search was performed in the Chinese BioMedical...

Full description

Bibliographic Details
Main Authors:	Yaowen Zhang, Lichao Yuan, Yongming Zhang, Xiuping Zhang, Minghuan Zheng, Moe H Kyaw
Format:	Article
Language:	English
Published:	Edinburgh University Global Health Society 2015-12-01
Series:	Journal of Global Health
Subjects:	RSV burden China
Online Access:	http://jogh.org/pdfviewer.aspx?pdf=documents/issue201502/jogh-05-020417.pdf

Similar Items

Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
by: Caroline Amand, et al.
Published: (2018-04-01)

Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
by: Chiara Azzari, et al.
Published: (2021-10-01)

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01)

Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
by: Sara Boccalini, et al.
Published: (2023-09-01)

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps
by: Ricardo Amorim Correa, et al.
Published: (2024-02-01)

Assessing the patient experience of respiratory syncytial virus infection: development of a patient-reported outcome measure
by: Carla (DeMuro) Romano, et al.
Published: (2023-02-01)

Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01)

Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries
by: Xavier Carbonell-Estrany, et al.
Published: (2022-11-01)

Respiratory syncytial virus causes more hospitalizations and deaths in equatorial Brazil than influenza (including during the 2009 pandemic)
by: WLADIMIR J. ALONSO, et al.
Published: (2020-03-01)

Molecular Mimicry between Respiratory Syncytial Virus F Antigen and the Human Proteome
by: Darja Kanduc
Published: (2023-01-01)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
by: Carlotta Biagi, et al.
Published: (2020-11-01)

Respiratory Syncytial Virus Matrix Protein Is Sufficient and Necessary to Remodel Host Mitochondria in Infection
by: MengJie Hu, et al.
Published: (2023-05-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

New Insights on Respiratory Syncytial Virus Prevention
by: Edyta Kopera, et al.
Published: (2023-11-01)

Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection
by: Kazuma Yagi, et al.
Published: (2022-04-01)

High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
by: Siripat Pasittungkul, et al.
Published: (2022-12-01)

Respiratory syncytial virus subtypes in children with bronchiolitis: does it correlate with clinical severity?
by: Shuo Yang, et al.
Published: (2024-02-01)

All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?
by: Sofie Schaerlaekens, et al.
Published: (2024-01-01)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
by: Sonia Bianchini, et al.
Published: (2020-12-01)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

Human respiratory syncytial virus and coronavirus rates in Iranian elderly patients more than 60 years old with acute respiratory symptoms
by: Shaian Tavakolian, et al.
Published: (2023-01-01)

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
by: Sathya N. Thulasi Raman, et al.
Published: (2023-12-01)

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
by: Patricia A. Jorquera, et al.
Published: (2016-12-01)

Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy
by: Alessia Lai, et al.
Published: (2024-01-01)

Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections
by: Ishan Garg, et al.
Published: (2022-07-01)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Mucosal Immune Responses to Respiratory Syncytial Virus
by: Megan V. C. Barnes, et al.
Published: (2022-03-01)

Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure
by: David Carballo, et al.
Published: (2021-09-01)

Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022)
by: Matteo Riccò, et al.
Published: (2023-07-01)

N6-methyladenosine modification contributes to respiratory syncytial virus infection
by: Zhu Li, et al.
Published: (2023-04-01)

Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus
by: Bo-Wen Sun, et al.
Published: (2024-01-01)

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities
by: Pritish Mondal, et al.
Published: (2022-02-01)

Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
by: Shibo Jiang, et al.
Published: (2013-01-01)

Back to the future of viruses: a case of triple coinfection caused by respiratory syncytial virus, human coronavirus OC43, and rhinovirus
by: Benjamin Davido, et al.
Published: (2023-05-01)

Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017
by: Jenna E. Holmen, et al.
Published: (2021-03-01)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
by: Yaneisi Vázquez, et al.
Published: (2019-06-01)

Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States
by: Elizabeth M. La, et al.
Published: (2024-12-01)

Features of respiratory syncytial virus infection in children in the post-COVID-19 era
by: Gheorghita Jugulete, et al.
Published: (2023-03-01)

Creola Bodies in Infancy with Respiratory Syncytial Virus Bronchiolitis Predict the Development of Asthma
by: Yumi Yamada, et al.
Published: (2010-01-01)

Subtractive Immunization as a Method to Develop Respiratory Syncytial Virus (RSV)—Specific Monoclonal Antibodies
by: Lotte Jacobs, et al.
Published: (2023-09-01)